Abstract
Background: Telemedicine has emerged as a transformative tool for healthcare delivery, particularly in rural areas where access to specialists and continuity of care is limited. Chronic diseases, such as diabetes, hypertension, and chronic kidney disease, impose a heavy burden on rural populations. This study evaluates the impact of telemedicine adoption on chronic disease management outcomes in rural primary care settings.Methods: A mixed-methods design was employed, combining a retrospective cohort analysis of electronic health records from 12 rural primary care clinics across three U.S. states (2019–2023) with semi-structured interviews of 24 healthcare providers. The study included 1,847 patients with type 2 diabetes, hypertension, or chronic kidney disease. Telemedicine adoption was measured as the proportion of encounters conducted via telehealth. Primary outcomes were glycated hemoglobin (HbA1c) levels, systolic blood pressure (SBP), and estimated glomerular filtration rate (eGFR). Multivariable regression models adjusted for patient demographics, comorbidities, and clinic characteristics.Results: Patients in clinics with high telemedicine adoption (≥40% of encounters) showed a mean HbA1c reduction of 0.8% (95% CI: 0.5–1.1) compared to low-adoption clinics. SBP decreased by 6.2 mmHg (95% CI: 3.8–8.6), and eGFR decline slowed by 2.1 mL/min/1.73m² per year (95% CI: 1.0–3.2). Provider interviews highlighted improved care coordination and patient engagement, but also identified barriers such as technology literacy and broadband access.Conclusions: Telemedicine adoption in rural primary care is associated with clinically meaningful improvements in chronic disease management. Policy efforts should focus on addressing digital divides to maximize benefits.
Keywords
telemedicine, chronic disease management, rural health, primary care, diabetes, hypertension, chronic kidney disease, health equity